Key Highlights

  • Global Health's FY2026 customer Revenue was A$7.184 million, down 2%, while recurring annual subscription revenue rose 5.5% to A$6.674 million.
  • Loss before tax narrowed 13% to A$758,000, and operating and development expenses fell A$880,000 to A$8.577 million.
  • Cash was A$475,000 at 31 March 2026, with all A$1.724 million of financing facilities drawn.

Global Health (ASX:GLH) is a Melbourne-based provider of healthcare software working to move a small, loss-making Business towards positive cash flow. Its FY2026 results, released on 26 to 27 August 2026, showed a smaller loss on slightly lower revenue, and the company has previously linked its outlook to AI-driven cost reductions and higher revenue. Figures are drawn from the FY2026 results summary and the March 2026 Quarterly Report unless stated otherwise.

What the company does and its stage

Global Health sells software to healthcare providers, covering electronic medical records, practice management, patient administration, secure messaging and consumer health records, delivered either as software-as-a-service or on-premises. Products named in the results include MasterCare Plus, the HotHealth digital front door, ReferralNet Secure Messaging and the Lifecard Personal Health Record. It is a commercial business with recurring revenue, rather than an explorer or clinical-stage developer, and is distinct from similarly named companies listed overseas.

FY2026 results

For the year to 30 June 2026, total customer revenue was A$7.184 million, down A$134,000 or 2% on the prior year. Recurring annual subscription revenue rose 5.5% to A$6.674 million and accounted for 93% of customer revenue, while professional services revenue fell A$530,000 to A$463,000. EBITDA after fully expensing Research and Development improved 28% to a loss of A$545,000 (FY2025: A$760,000). Loss before tax narrowed 13% to A$758,000 (A$866,000), and operating and development expenses fell A$880,000 to A$8.577 million.

The company said its FY2027 focus is to grow Recurring Revenue by adding sales staff and indirect channel partners, to roll out AI features including a Partnership with Heidi Health and an AI receptionist, and to integrate with Best Practice, a general-practice software provider. These are stated plans rather than results.

Cash and funding

The FY2026 results summary does not state a cash balance. In the March 2026 quarter, cash was A$475,000, down from A$1.037 million at 31 December 2025. Customer receipts were A$1.847 million, up 25% on the March 2025 quarter, and the operating outflow was A$500,000. All A$1.724 million of the company's financing facilities were drawn, leaving none unused, and the company estimated 0.95 of a quarter of funding.

Year-to-date receipts to March were A$7.013 million, up 23%, and staff costs fell 31% in the quarter. Three new customer sites went live during the quarter, with five more due in the June quarter, when the Heidi and Best Practice integrations were also scheduled. The company said it had capacity to raise further funds if required and forecast positive Cash Flow from July 2026, dependent on AI-driven cost reductions and higher revenue. No new Equity raising has been announced; any such raising would dilute existing holders.

What to Watch

The June 2026 quarterly report, released on 23 July 2026, and subsequent quarterly reports will show whether the company's positive cash flow forecast from July 2026 has been met. Australian healthcare software is a competitive field with larger practice-management and records vendors, and customers can be slow to switch systems. Reliance on third-party integrations and AI partnerships adds execution risk, and a cash balance that is thin relative to quarterly outflows leaves limited room for delays.